Continuing Education (CE)
Continuing Education (CE)
Bayer has sponsored a variety of continuing education (CE) programs, which were developed to improve awareness and understanding of hemophilia A.
All accredited CE/CME programs listed below were created independently by third-party providers and follow the standards set forth in the ACCME Standards for Commercial Support/Integrity and Independence in Accredited Continuing Education, or other similar accrediting organizations. Responsibility and control over selection, content, faculty, educational materials, and venue for the educational programs belong solely to the providers and/or accreditors. Bayer does not provide any guidance regarding the content or faculty for any programs receiving funding.
The list below is limited to CE programs supported by Bayer.
Last updated "February 2026".
Pediatric Hemophilia A: Early Factor VIII Use and Lifelong Treatment Planning
Jonathan M. Ducore, MD, MPH; Mindy L. Simpson, MD; Anne M. Gonzales, PT, DPT; Kim L. Schafer, MSN, FNP-C
Learning Objectives:
Recognize the clinical importance of early FVIII prophylaxis initiation in young pediatric patients with hemophilia A
Examine the clinical consequences of untreated hemarthroses (i.e., joint remodeling and chronic pain) and its management, including pharmacologic, physiotherapeutic, and surgical options
Review the landscape of current pharmacologic therapies, including extended half-life (EHL) factor concentrates in improving long-term clinical outcomes in hemophilia
Apply the latest safety and efficacy data to support ongoing EHL FVIII prophylaxis in children and adolescents
Implement comprehensive, multidisciplinary treatment plans that include physical therapy, psychosocial support, and family education
Adapt prophylactic regimens to address the variability in physical activity, psychosocial development, and treatment adherence commonly seen during adolescence
Develop individualized transition plans to ensure continuity of care from pediatric to adult service
2.00 CME Credit
Online Webinar Updates in Hemophilia: Approaches to the Comprehensive
Care of Women with Hemophilia A using rFVIII
Steven Pipe, MD; Maria Elisa Mancuso, MD, PhD; Leonard Valentino, MD and Angela Weyand, MD
Learning Objectives:
Describe the epidemiology, characteristics and clinical presentation of hemophilia A carriers and recognize the significance of timely and accurate diagnosis
Summarize the recent guidelines and nomenclature for managing hemophilia carriers
Recognize the importance of registering hemophilia carriers at Hemophilia Treatment Centers (HTC) to facilitate comprehensive monitoring of patients
Identify challenges faced by multidisciplinary teams in delivering comprehensive care to hemophilia carriers
1.25 CME Credit
Intended Audience: Physicians (hematologists/hemophilia specialists), nurses, other Hemophilia Treatment Center (HTC) team members, patients/caregivers, and managed care personnel
Follow Us
